Inflammation and cardiovascular diseases.
作者信息
Wang Hui, Jing Zhi-Cheng
机构信息
Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100730, China.
出版信息
Chronic Dis Transl Med. 2020 Nov 3;6(4):215-218. doi: 10.1016/j.cdtm.2020.09.003. eCollection 2020 Dec.
Abstract
摘要
相似文献
1
Inflammation and cardiovascular diseases.炎症与心血管疾病。
Chronic Dis Transl Med. 2020 Nov 3;6(4):215-218. doi: 10.1016/j.cdtm.2020.09.003. eCollection 2020 Dec.
2
Infectious agents and inflammation in donated hearts and dilated cardiomyopathies related to cardiovascular diseases, Chagas' heart disease, primary and secondary dilated cardiomyopathies.供体心脏中的感染因子与炎症以及与心血管疾病、恰加斯病、原发性和继发性扩张型心肌病相关的扩张型心肌病。
Int J Cardiol. 2015 Jan 15;178:55-62. doi: 10.1016/j.ijcard.2014.10.133. Epub 2014 Oct 23.
3
The Role of Signaling Pathways of Inflammation and Oxidative Stress in Development of Senescence and Aging Phenotypes in Cardiovascular Disease.炎症和氧化应激信号通路在心血管疾病衰老表型发生发展中的作用。
Cells. 2019 Nov 4;8(11):1383. doi: 10.3390/cells8111383.
4
Interplay of inflammation, oxidative stress and cardiovascular disease in rheumatoid arthritis.类风湿关节炎中炎症、氧化应激与心血管疾病的相互作用
Heart. 2018 Dec;104(24):1991-1992. doi: 10.1136/heartjnl-2018-313313. Epub 2018 Aug 2.
5
[Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].[心肌病的分类及心内膜心肌活检指征再探讨]
Herz. 2009 Feb;34(1):55-62. doi: 10.1007/s00059-009-3195-8.
6
The Emerging Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Metabolic Cardiomyopathies.心血管磁共振成像在代谢性心肌病评估中的新兴作用。
Horm Metab Res. 2015 Aug;47(9):623-32. doi: 10.1055/s-0035-1555913. Epub 2015 Jul 21.
7
Assessing perinatal depression as an indicator of risk for pregnancy-associated cardiovascular disease.评估围产期抑郁症作为妊娠相关心血管疾病风险指标的情况。
Cardiovasc J Afr. 2016 Mar-Apr;27(2):119-22. doi: 10.5830/CVJA-2015-087.
8
Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies.心肌疾病发病机制中的炎症的分子基础。
Int J Mol Sci. 2020 Sep 4;21(18):6462. doi: 10.3390/ijms21186462.
9
New Insights into the Role of Ferroptosis in Cardiovascular Diseases.铁死亡在心血管疾病中的作用新见解。
Cells. 2023 Mar 10;12(6):867. doi: 10.3390/cells12060867.
10
Inflammation and cardiac outcome.炎症与心脏结局。
Curr Opin Infect Dis. 2011 Jun;24(3):259-64. doi: 10.1097/QCO.0b013e328344f50f.
引用本文的文献
1
Interacting and joint effects of frailty and inflammation on cardiovascular disease risk and the mediating role of inflammation in middle-aged and elderly populations.衰弱与炎症对心血管疾病风险的交互作用和联合效应以及炎症在中老年人群中的中介作用
BMC Cardiovasc Disord. 2025 Feb 20;25(1):118. doi: 10.1186/s12872-025-04567-1.
2
Exploring the association between phase angle of bioimpedance at 50 kHz and cardiovascular risk.探讨 50 kHz 生物阻抗相角与心血管风险之间的关系。
BMC Cardiovasc Disord. 2024 Oct 29;24(1):606. doi: 10.1186/s12872-024-04211-4.
3
Research progress on the improvement of cardiovascular diseases through the autonomic nervous system regulation of the NLRP3 inflammasome pathway.通过自主神经系统调节NLRP3炎性小体通路改善心血管疾病的研究进展
Front Cardiovasc Med. 2024 Apr 8;11:1369343. doi: 10.3389/fcvm.2024.1369343. eCollection 2024.
本文引用的文献
1
Environmental heavy metals and cardiovascular diseases: Status and future direction.环境重金属与心血管疾病：现状与未来方向
Chronic Dis Transl Med. 2020 Apr 3;6(4):251-259. doi: 10.1016/j.cdtm.2020.02.005. eCollection 2020 Dec.
2
Cardiomyopathies in China: A 2018-2019 state-of-the-art review.中国的心肌病：2018 - 2019年最新综述
Chronic Dis Transl Med. 2020 Jul 5;6(4):224-238. doi: 10.1016/j.cdtm.2020.05.006. eCollection 2020 Dec.
3
Targeting Inflammation to Reduce Residual Cardiovascular Risk.靶向炎症以降低残余心血管风险。
Curr Atheroscler Rep. 2020 Sep 3;22(11):66. doi: 10.1007/s11883-020-00883-3.
4
2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications.2019新型冠状病毒：关于危险因素、心肌损伤、治疗及临床意义的心血管见解
Chronic Dis Transl Med. 2020 Dec;6(4):246-250. doi: 10.1016/j.cdtm.2020.06.002. Epub 2020 Jun 13.
5
Prevalence and prognostic relevance of myocardial inflammation and cardiotropic viruses in non-ischemic dilated cardiomyopathy.非缺血性扩张型心肌病中心肌炎和嗜心性病毒的流行情况及其预后相关性。
Cardiol J. 2022;29(3):441-453. doi: 10.5603/CJ.a2020.0088. Epub 2020 Jun 22.
6
Inflammation shapes pathogenesis of murine arrhythmogenic cardiomyopathy.炎症影响小鼠心律失常性心肌病的发病机制。
Basic Res Cardiol. 2020 Jun 12;115(4):42. doi: 10.1007/s00395-020-0803-5.
7
COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection.2019冠状病毒病、免疫肿瘤学与心血管疾病：交叉领域的观点
J Cardiovasc Transl Res. 2020 Jun;13(3):347-348. doi: 10.1007/s12265-020-10013-8.
8
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.白细胞介素-1 和炎症小体作为心血管疾病的治疗靶点。
Circ Res. 2020 Apr 24;126(9):1260-1280. doi: 10.1161/CIRCRESAHA.120.315937. Epub 2020 Apr 23.
9
COVID-19 for the Cardiologist: Basic Virology, Epidemiology, Cardiac Manifestations, and Potential Therapeutic Strategies.心脏病专家眼中的COVID-19：基础病毒学、流行病学、心脏表现及潜在治疗策略
JACC Basic Transl Sci. 2020 Apr 10;5(5):518-536. doi: 10.1016/j.jacbts.2020.04.002. eCollection 2020 May.
10
Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan): rationale for adoption in SARS-CoV-2 patients.中性肽链内切酶抑制剂-血管紧张素II受体阻滞剂组合（沙库巴曲/缬沙坦）：应用于2019冠状病毒病患者的理论依据
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):135-136. doi: 10.1093/ehjcvp/pvaa028.
Zotero 插件